When the FDA’s advisory panel includes members with financial stakes in pharmaceutical companies (one even holding a patent for a nicotine gum), you have to wonder where the loyalties really lie. As Phillip Morris’ long-lobbied and long-awaited Family Smoking Prevention and Tobacco Control Act the Tobacco Act gave unprecedented power to the FDA to regulate tobacco products, Phillip Morris is now whining about the conflicting interests of panel members. Like PM wasn’t aware you can buy policy…. Read more:
The Examiner 05/14/10: Timothy P. Carney: Big Pharma rumbles with Big Tobacco